A prognostic model for patients with primary extramedullary multiple myeloma
Background: Extramedullary disease is a manifestation of multiple myeloma, the prognosis of which remains poor even in the era of novel drugs. Therefore, we aimed to develop a predictive model for patients with primary extramedullary multiple myeloma (EMM).Methods: Clinical and laboratory data of pa...
Main Authors: | Limei Zhang, Shuzhao Chen, Weida Wang, Yun Wang, Yang Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1021587/full |
Similar Items
-
Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma
by: Zhang L, et al.
Published: (2023-01-01) -
Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study
by: Xuxing Shen, et al.
Published: (2022-12-01) -
Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease
by: Jing Wang, et al.
Published: (2023-12-01) -
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
by: Duan F, et al.
Published: (2021-08-01) -
Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
by: Jiaxuan Xu, et al.
Published: (2022-10-01)